期刊文献+

布氏杆菌PBP_(39)蛋白抗原表达及免疫效果的研究 被引量:2

Expression and immunogenicity of PBP_(39) recombinant protein of Brucella
下载PDF
导出
摘要 目的 获得纯化的布氏杆菌PBP3 9重组蛋白抗原,观察PBP3 9重组蛋白的免疫原性。方法 扩增不同种布氏杆菌PBP3 9基因,测序、连接表达载体PET3 2a ,诱导表达,柱纯化PBP3 9重组蛋白抗原,免疫BALB/c小鼠,ELISA检测抗体及抗体亚型。结果 我国牛、羊、猪布氏杆菌PBP3 9基因与国外已报道的PBP3 9编码基因不完全相同。在蛋白N端5 8位碱基后多一G ,造成移码突变。故在85、86、87位编码终止子TCA。而在13 4、13 5、13 6位的ATG又编码了新的起始密码。布氏杆菌PBP3 9蛋白在大肠杆菌高效表达,表达量达40 % ,纯化重组蛋白抗原免疫BALB/c小鼠,产生了较高水平的特异性抗体免疫应答,抗体亚型主要是IgG1。结论 我国牛、羊、猪布氏杆菌PBP3 9编码抗原蛋白同国外已报道的不完全相同,纯化的PBP3 9重组蛋白抗原可诱导高水平的抗体反应,为筛选布氏杆菌病新型疫苗保护性抗原分子奠定了基础。 Objective To obtain recombinant PBP 39 protein of Brucella and study its immunity. Methods The PBP 39 protein DNA was amplified by PCR, cloned into PET32a vector and transformed into E.coli BL21 for expression. The BALB/c mice were immunized with the purified recombinant protein. The antibody level and specific antibody against PBP 39 protein was detected by ELISA. Results The site of ATG was not as the same as PBP 39 reported in GenBank. At the N terminal, there was a frameshift mutation at 58 site. The Brucella PBP 39 protein expressed highly in the E.coli. Experimental animals exhibited specific antibody that was detectable by ELISA. IgG1-specific antibody titers of the recombinant PBP 39 protein were higher than IgG2a-specific antibody. Conclusion The PBP 39 protein is special in China and induce immune response.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第9期817-820,共4页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目 ( 30 170 853)~~
关键词 布氏杆菌PBP39 重组蛋白抗原 免疫原性 Brucella PBP 39 recombinant protein antigen immunity
  • 相关文献

参考文献5

  • 1Schurig G G, Sriranganathan N, Corbel M J. Brucellosis vaccines: past,present and future[J]. Vet Microbiol, 2002, 90(1-4): 479-496.
  • 2Davis D S, Elzer P H. Brucella vaccines in wildlife[J]. Vet Microbiol,2002, 90(1-4): 533-544.
  • 3Al Mariri A, Tibor A, Mertens P, et al. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant [ J ].Infect Immun, 2001, 69(8): 4816-4822.
  • 4Denoel P A, Vo T K, Tibor A, et al. Characterization, occurrence, and molecular cloning of a 39-kilodalton Brucella abortus cytoplasmic protein immunodominant in cattle[J]. Infect Immun, 1997, 65(2): 495 - 502.
  • 5Denoel P A, Vo T K, Weynants V E, et al. Identification of the major Tcell antigens present in the Brucella melitensis B115 protein preparation Brucellergene OCB[J]. J Med Microbiol, 1997, 46(9): 801-806.

同被引文献15

  • 1苏永锋.礼泉县布鲁杆菌病防治工作回顾[J].中国地方病学杂志,2005,24(5):571-571. 被引量:1
  • 2Ko J,Splitter GA.Molecular host-pathogen interaction in brucellosis:current understanding and future approaches to vaccine development for mice and humans[J].Clin Microbiol Rev,2003,16(1):65-78.
  • 3Oliveira SC,Splitter GA.Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection[J].Vaccine,1996,14(10):959-962.
  • 4Velikovsky CA,Goldbaum FA,Cassataro J,et al.Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544independently of the adjuvant formulation used[J].Infect Immun,2003,71(10):5750-5755.
  • 5Velikovsky CA,Cassataro J,Giambartolomei GH,et al.A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice[J].Infect Immun,2002,70(5):2507-2511.
  • 6Al-Mariri A,Tibor A,Mertens P,et al.Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant[J].Infect Immun,2001,69(8):4816-4822.
  • 7Stabel TJ,Mayfield JE,Tabatabai LB,et al.Oral immunization of mice with attenuated Salmonella typhimurium containing a recombinant plasmid which codes for production of a 31-kilodalton protein of Brucella abortus[J].Infect Immun,1990,58(7):2048-2055.
  • 8Tibor A,Weynants V,Denoel P,et al.Molecular cloning,nucleotide sequence,and occurrence of a 16.5-kilodalton outer membrane protein of Brucella abortus with similarity to pal lipoproteins[J].Infect Immun,1994,62(9):3633-3639.
  • 9Burgos J S.Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis[J].Med Oncol,2005,22(2):113-121.
  • 10Kilger E,Kieser A,Baumann M,et al.Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1,which simulates an activated CD40 receptor[J].EMBO J,1998,17(6):1700-1709.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部